Showing results (1-10 of 23) with videos related to
Sort By:
Pageof 3
Frontiers in Bioscience (Scholar Edition)|December 29, 2011
Histamine receptor subtypes: a century of rational drug designMiriam Walter, Holger StarkEuropean Journal of Pharmacology|July 12, 2011
The histamine H₄ receptor: targeting inflammatory disordersMiriam Walter, Tim Kottke, Holger StarkPsychopharmacology|March 12, 2013
Influence of the novel histamine H₃ receptor antagonist ST1283 on voluntary alcohol consumption and ethanol-induced place preference in miceAmine Bahi, Bassem Sadek, Stephan J Schwed, et al.Drug Design, Development and Therapy|June 13, 2014
Anxiolytic and antidepressant-like activities of the novel and potent non-imidazole histamine H₃ receptor antagonist ST-1283Amine Bahi, Johannes Stephan Schwed, Miriam Walter, et al.Drug Design, Development and Therapy|November 18, 2016
Anticonvulsant effects of isomeric nonimidazole histamine H3 receptor antagonistsBassem Sadek, Ali Saad, Johannes Stephan Schwed, et al.Oncoimmunology|April 9, 2016
An epitope-specific novel anti-EMMPRIN polyclonal antibody inhibits tumor progressionMiriam Walter, Elina Simanovich, Vera Brod, et al.European Journal of Medicinal Chemistry|March 22, 2014
Non-imidazole histamine H3 receptor ligands incorporating antiepileptic moietiesBassem Sadek, Johannes Stephan Schwed, Dhanasekaran Subramanian, et al.Oncoimmunology|February 16, 2017
Inhibition of tumor growth and metastasis by EMMPRIN multiple antigenic peptide (MAP) vaccination is mediated by immune modulationElina Simanovich, Vera Brod, Maya M Rahat, et al.Cytotherapy|May 10, 2017
Preclinical data support leveraging CS1 chimeric antigen receptor T-cell therapy for systemic light chain amyloidosisMichael Rosenzweig, Ryan Urak, Miriam Walter, et al.Plos Computational Biology|February 24, 2012
DOGS: reaction-driven de novo design of bioactive compoundsMarkus Hartenfeller, Heiko Zettl, Miriam Walter, et al.Pageof 3